PHT Corporation Leads Pharmaceutical Industry in Patient-Reported Clinical Trial Data Integration

Global ePRO leader launches the PHT Integration Engine, a product that enables sponsors and CROs to integrate multiple data streams in real time

PHT Corporation Leads Pharmaceutical Industry in Patient-Reported Clinical Trial Data Integration

For PHT CorporationBrenda Nashawaty, 617-688-3253

Global Systems innovator reinforced the importance of integrating multiple data streams to dramatically improve clinical trial efficiencies and streamline timelines by releasing its exclusive PHT Integration Engine.

PHT’s Integration Engine is an automated, validated system that is completely reusable and expandable. It provides unequaled economies of scale and eliminates the burden on the site and sponsor by integrating data in real time. Projects that previously required months to complete manually are now accomplished in hours. A recent integration transferred over 10,000 forms for 263 subjects in just 90 minutes.

PHT Vice President of Marketing Sheila Rocchio, MBA, explained, “We’re constantly looking for ways to help customers integrate multiple streams of patient data, and reduce data entry and data management burdens. By integrating with leading companies in eClinical research, PHT minimizes time-consuming data cleaning tasks to allow sites, sponsors and CROs to focus on what they care about most: good science and helping patients.”

The PHT Integration Engine takes advantage of PHT’s market-leading ® online reporting system, which natively generates CDISC ODM XML for integration with a broad range of eClinical systems.

PHT recently completed integration with , a leading electronic data capture (EDC) and clinical data management (CDM) solution, for a sponsor that required patient medication intake date timestamps collected on PHT’s ® System to be populated in the Medidata Rave database. By integrating multiple data streams, sponsors and CROs realize significant cost and time efficiencies.

Anne Zieliniski, Medidata’s Vice President of Alliances, said, “Clinical trials need a range of flexible technologies and the Medidata Rave platform was designed to support seamless integration with other clinical systems through our robust APIs. PHT has been a long-time integration partner of Medidata Solutions and is the first ePRO provider that supports both metadata integration and clinical data integration with Rave.”

PHT’s Sheila Rocchio added, “The PHT Integration Engine framework is an adaptable and reusable architecture. Some trial sponsors still think integration among eClinical systems is costly, time consuming and error prone, but this is no longer the case. Today, integration is the most cost effective, efficient and accurate way for a sponsor or CRO to stay on top of every aspect of data related to a clinical trial, and it’s in real time.”

For more information about PHT’s Integration Engine, email or visit

PHT Corporation helps biopharmaceutical companies and CROs conduct clinical studies with greater confidence, ease and accuracy. We enable our clients to gain insights, through measuring how patients feel and function, that help speed therapies to market and improve lives. From our 500+ global trial experiences including 16+ regulatory approvals, we offer the breadth, history and scientific expertise today’s market demands. PHT's proven Systems collect patient-driven eData via smartphones, tablets and the web. This data, available via StudyWorks® online portal, provides sponsors and clinicians with a real-time window to patients between visits for improved protocol compliance and safety monitoring. For more information on Patient Driven eData, review the interactive content and demonstrations at . Follow PHT on .

PHT, LogPad and SitePad are registered trademarks of PHT Corporation. NetPRO is a trademark of PHT Corporation.

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.